Prevalence of the American College of Rheumatology classification criteria in a group of 162 systemic lupus erythematosus patients from Croatia

Croatian Medical Journal

Volumn 53, Issue 2, 2012, Pages 149-154

  Cerovec, Mislav ^a   Anić, Branimir ^a   Padjen, Ivan ^a   Čikeš, Nada ^a  

^a KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADULT; AGED; ARTHRITIS; ARTICLE; CLINICAL FEATURE; CROATIA; DISEASE CLASSIFICATION; FEMALE; HEMATOLOGIC DISEASE; HUMAN; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHOTOSENSITIVITY DISORDER; RASH; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED, 80 AND OVER; CROATIA; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RHEUMATOLOGY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84862569376     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2012.53.149     Document Type: Article

References (18)

1. Anic B, Bosnic D. Systemic lupus erythematosus [in Croatian]. In: Vrhovac B, Jakšic B, Reiner Ž, Vucelic B, editors. Interna medicina. 4th ed. Zagreb: Naklada Ljevak; 2008. p. 1386-90.
2. Domsic RT, Ramsey-Goldman R, Manzi S. Epidemiology and classification of systemic lupus erythematosus. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 4th ed. Philadelphia (PA): Mosby-Elsevier; 2008. p. 1211-6.
3. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
4. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-7.
5. Cikeš N. Neuropsychiatric manifestations of systemic lupus erythematosus [in Croatian]. Reumatizam. 2009;56:29-33.
6. Cikeš N. Central nervous system involvement in systemic connective tissue diseases. Clin Neurol Neurosurg. 2006;108:311-7.
7. Cikeš N, Sentic M, Bosnic D, Markeljevic J, Anic B, Škorak I, et al. Cardiac lesions in patients with systemic lupus erythematosus and antiphospholipid syndrome [abstract]. Lupus. 1995;4:76.
8. Anic B, Sentic M, Ivekovic R, Bosnic D, Markeljevic J, Pucar I, et al. Thyroid autoimmunity in patients with systemic lupus erythematosus [abstract]. Lupus. 1995;4:2.
9. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore). 1999;78:167-75.
10. Manger K, Manger B, Repp R, Geisselbrecht M, Geiger A, Pfahlberg A, et al. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis. 2002;61:1065-70.
11. Gilboe IM, Husby G. Application of the 1982 revised criteria for the classification of systemic lupus erythematosus on a cohort of 346 Norwegian patients with connective tissue disease. Scand J Rheumatol. 1999;28:81-7.
12. Ganczarczyk L, Urowitz MB, Gladman DD. Latent lupus. J Rheumatol. 1989;16:475-8.
13. Swaak AJ, van de Brink H, Smeenk RJ, Manger K, Kalden JR, Tosi S, et al. Incomplete lupus erythematosus: Results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT). Rheumatology (Oxford). 2001;40:89-94.
14. Mosca M, Bombardieri S. Assessing remission in systemic lupus erythematosus. Clin Exp Rheumatol. 2006;24(6 Suppl 43):S-99-104.
15. Aringer M, Smolen J. Systemic lupus erythematosus - activity and outcome [in German]. Z Rheumatol. 2006;65:103-9.
16. Freire EA, Maia IO, Nepomuceno JC, Ciconelli RM. Damage index assessment and quality of life in systemic lupus erythematosus patients (with long-term disease) in Northeastern Brazil. Clin Rheumatol. 2007;26:423-8.
17. Griffiths B, Mosca M, Gordon C. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol. 2005;19:685-708.
18. Urowitz MB, Gladman DD. Measures of disease activity and damage in SLE. Baillieres Clin Rheumatol. 1998;12:405-13.